08/19/2019 /
In the present study, the team evaluated the therapeutic potential of donepezil, a reversible acetylcholinesterase inhibitor approved by the FDA, in a mouse model of Dravet syndrome (Scn1a +/-).
08/19/2019 /
In order to avoid prejudices and potentially harmful self-medication, physicians and healthcare providers are called to become familiar with the substance and to inform patients adequately.
08/15/2019 /
The improved access to genomic data will allow clinical teams to understand the causes of a patient’s epilepsy and develop personalized care.
08/14/2019 /
This study identifies the unique epilepsy self-management needs of people with epilepsy from underserved populations.
08/12/2019 /
This small study demonstrated the ‘toolkits’ potential as a method of increasing knowledge about epilepsy and risk management.
08/09/2019 /
Focal epilepsy may accelerate widespread progressive cortical thinning to a greater degree than that observed in normal aging.
08/09/2019 /
Mutations of a gene implicated in long QT syndrome in humans may trigger seizures because of their direct effects on certain classes of neurons in the brain.
08/08/2019 /
The FDA has granted Orphan Drug designation to STK-001 (Stoke Therapeutics) for the treatment of Dravet syndrome.
08/08/2019 /
The UK’s National Institute for Health and Care Excellence (NICE) said it is currently unable to recommend cannabis-based medical products for severe treatment-resistant epilepsy.
